Repaglinide Metformin Tablets (Ⅰ)
Function and Efficacy
Not yet clear.
Ingredients
Repaglinide metformin.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| RepaglinideIngredients |
Not yet clear More |
135062-02-1 | 44 | |
| MetforminIngredients |
Not yet clear More |
657-24-9 | 0 |
Appearance
This product is in the form of tablets.
Indication
No data yet
Usage and Dosage
Oral administration, 3 times a day, 1 tablet each time.
Adverse Reactions
Not yet clear.
Precautions
Not yet clear.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Keep sealed.
Packaging Specification
Each tablet contains 1 mg of repaglinide and 0.5 g of metformin hydrochloride
Validity Period
24 months
Manufacturer
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
-
Founded in:
1995-07-26 -
Address:
Lianyungang Economic and Technological Development Zone, Jiangsu Province -
Tax NO.:
913207006083959289 -
Registered Funds:
1,000,000,000 Yuan -
Website:
-
Email: